Predicting BRAF Mutations in Cutaneous Melanoma Patients Using Neural Network Analysis
In conclusion, the developed MLP model, which relies on the assessment of 6 variables, can predict the BRAF mutation status in patients with CM, supporting decisions on patient management.
Saved in:
| Main Authors: | Oleksandr Dudin, Ozar Mintser, Vitalii Gurianov, Nazarii Kobyliak, Dmytro Kaminskyi, Alina Matvieieva, Roman Shabalkov, Artem Mashukov, Oksana Sulaieva |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-01-01
|
| Series: | Journal of Skin Cancer |
| Online Access: | http://dx.doi.org/10.1155/jskc/3690228 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Unveiling risk factors for post-COVID-19 syndrome development in people with type 2 diabetes
by: Anton Matviichuk, et al.
Published: (2024-12-01) -
Genetic alterations affect immune contexture of non-small cell lung cancer: Ukrainian study
by: Denys Kozakov, et al.
Published: (2025-07-01) -
Cutaneous Side Effects of BRAF Inhibitors in Advanced Melanoma: Review of the Literature
by: Bilgen Gençler, et al.
Published: (2016-01-01) -
The combination of mutations in BRAF and NRAS genes within a one tumor in patients with cutaneous melanoma
by: M. B. Aksenenko, et al.
Published: (2019-10-01) -
Role of eIF6 in Modulating Response to BRAF Inhibitors and Acquired Resistance in Cutaneous Melanoma
by: G. Kyriakopoulos, et al.
Published: (2024-01-01)